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1. Introduction 
1.1 Terminology, epidemiology and heredity 
Congenital glaucoma is a major cause of blindness in children, despite its low incidence 
(1:10,000 births)1. This category includes isolated congenital glaucoma (also called primary 
congenital glaucoma) and glaucomas associated with other developmental anomalies, either 
systemic or ocular.  
Juvenile glaucoma is the term used to designate cases in which the pressure rise develops 
after the third birthday but before the age of 16 years.2 The enlargement of the eye 
(buphthalmos) is least common, despite the elevated intraocular pressure. Gonioscopy is 
normal or reveals trabeculodysgenesis. This condition may simulate the primary open-angle 
glaucoma. 
The eyes with primary congenital glaucoma have an isolated maldevelopment of the 
trabecular meshwork not associated with others developmental ocular anomalies or ocular 
diseases that can raise intraocular pressure. It’s the most common glaucoma of infancy, 
occurring in about 1: 30,000 live births1. 
Primary congenital glaucoma is a bilateral disease in about 75% of cases, with males 
accounting for approximately 65% of cases. 2 Most cases are sporadic in occurrence, with no 
evident hereditary pattern. In approximately 10% in which a hereditary pattern is evident, it 
generally is believed to be autosomal recessive. Many authors believe the inheritance 
pattern is polygenic.1 
1.2 Pathogenesis 
Clinical evidence supports the theory that the obstruction to aqueous flow, with a resultant 
increase in intraocular pressure, is located at the trabecular sheets. This obstruction is caused 
by maldevelopment of the anterior chamber angle, unassociated with any other major 
ocular anomalies (isolated trabeculodysgenesis).2 
Clinically, trabeculodysgenesis is characterized by absence of the angle recess, with the iris 
inserted into the surface of the trabeculum in one of two configurations:2 
a. Flat iris insertion: the iris inserts flatly into the thickened trabeculum at or anterior to 
the scleral spur. 
b. Concave iris insertion: is less common. The plane of the iris is well posterior to the 
normal position of the scleral spur. However, the anterior iris stroma continues upward 
and over the trabecular meshwork, obscuring the scleral spur and the others angular 
structures. 
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1.3 Clinical presentation  
Frequently, the first symptoms of primary congenital glaucoma are epiphora, photophobia 
and blepharospasm. These symptoms occur secondary to the corneal epithelial edema 
caused by elevated intraocular pressure.  
The elevated intraocular pressure also causes an enlargement of the eye (buphthalmos) 
(Figure 1), mainly at the corneoscleral junction. Stretching of the zonules can cause lens 
subluxation.3 
 
 
Fig. 1. Buphthalmos and corneal edema (Courtesy Prof. Augusto Paranhos Jr.) 
 
 
 
Fig. 2. Haab’s striae (Courtesy Prof. Ernst Oltrogge) 
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As the cornea stretches, ruptures of the Descemet´s membrane allow influx of aqueous into 
the corneal stroma and epithelium, causing an increase in edema and haze. The breaks in 
Descemet´s membrane (Haab´s striae - Figure 2) are single or multiples, and appear as 
elliptical parallel ridges on the posterior cornea.3 The Haab’s striae are usually horizontal or 
oblique in contrast to traumatic Descemet’s tears that are vertically oriented. Progressive 
myopia may occur if the elevated intraocular pressure persists. 
Pain is unusual in the older child with glaucoma, unless corneal erosion or ulceration 
appear.   
In contrast to the adult eye, the scleral canal in the infant eye enlarges as part of the 
generalized enlargement of the globe, and the lamina cribrosa may bow posteriorly, in 
response to elevated intraocular pressure. Therefore, cup size may be increased from 
neuronal loss, enlargement of the scleral canal, or both.2 
1.4 Initial evaluation and follow-up (Flowchart 1) 
Depending on the patient’s age and ability to cooperate, either an office examination or an 
examination using general anesthesia with intravenous ketamine is required to evaluate the 
child with glaucoma.3 
Examination of the corneal diameter should be undertaken first, followed by applanation 
tonometry, slit lamp examination, gonioscopy and evaluation of the optic discs.  
a. corneal diameter should be measured in both vertical and horizontal meridians with 
calipers. The horizontal diameter is usually easier to measure and more accurate than 
the vertical, due an excessive corneal limbus stretching in this meridian. A diameter > 
12 mm prior to the age of one year should be viewed with suspicion.4 
b. Intraocular pressure could be measure with a Goldmann tonometer, Perkins tonometer 
or Tono-Pen. Elevated intraocular pressure by itself, unless extreme, is not sufficient to 
confirm a diagnosis of glaucoma. It is necessary to depend on signs such as increased 
corneal diameter and corneal thickness, increased cup-disc ratio or evidence of 
trabeculodysgenesis to confirms the diagnosis.  
The normal intraocular pressure in children under general anesthesia is unknown. 
Some authors consider glaucoma suspects children with IOP above 14 mm Hg.4 
Nevertheless, its important to remember the major of anesthetics reduces the 
intraocular pressure, while ketamine may increase intraocular pressure.4 
c. The slit lamp examination may reveal corneal edema, haze and ruptures of the 
Descemet´s membrane (Haab´s striae). The anterior chamber is deep, with iris 
hypoplasia sometimes showing the iris pigment epithelium.4  Stretching of the zonules 
can cause lens subluxation. 
d. Gonioscopy should be performed with a Koeppe lens or one of the others goniolenses. 
Gonioscopy of the eye with congenital glaucoma reveals an anterior insertion of the iris 
directly into the trabecular meshwork. This insertion most commonly is flat (Figure 3), 
although a concave insertion may also be seen. The level of the iris insertion may vary 
at different areas of the angle. No pigment band is present, but a thin section of ciliary 
body can be seen through the thickened trabeculum. The peripheral iris may show a 
thinning of the anterior stroma. 
e. Opthalmoscopy of the eye with congenital glaucoma may be impossible in some cases, 
due corneal edema and/or haze. The infant glaucomatous cup usually has a 
configuration different from that of an adult glaucomatous cup. It’s more commonly 
round, steep walled and central.1 The cup tends to enlarge circumferentially with 
progression of the glaucoma. In the very young, cupping can decrease after intraocular 
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pressure is brought under control. To provide records for future comparison, it is best 
to take photographs of the optic nerve head, whenever possible. 
f. Auxiliary exams: the measurement of axial length by A-scan ultrasonography has been 
recommended by some authors for routine use in the diagnosis and follow-up of 
congenital glaucoma.4 The eyes with congenital glaucoma commonly present an 
elevated axial length due the elevated intraocular pressure.  
 
 
 
Fig. 3. Gonioscopy showing the flat iris configuration (Courtesy Prof. Augusto Paranhos Jr.) 
The standard automated perimetry may be useful in the diagnosis and follow-up of 
congenital glaucoma patients above 7 years old.4 Unfortunately, there is not adequate 
software to analyze children in any automated perimeters.  
Patients with congenital glaucoma require follow-up examinations for life. The IOP 
measure, ophthalmoscopy and visual field analysis, when it is possible, must be realized at 
least every 3 to 6 months, depending the glaucoma severity. The long-term prognosis for 
intraocular pressure control in successfully treated cases of congenital glaucoma appears 
excellent. However, the visual outcome and IOP control in unsuccessfully treated cases after 
one or two surgical procedures, may be poor. 
1.5 Differential diagnosis 
Many conditions may confuse the primary congenital glaucoma diagnosis and present 
corneal edema, epiphora, corneal enlargement or elevated intraocular pressure. 2 
a. Cloudy cornea at birth: trauma with breaks in the Descemet´s membrane, intrauterine 
rubella, metabolic disorders (mucopolysaccharidoses) and congenital hereditary 
endothelial dystrophy. 
b. Corneal enlargement: megalocornea and high myopia. 
c. Epiphora: congenital obstruction of the nasolacrimal duct. 
d. Secondary infantile glaucoma: trauma, ectopia lentis, uveitis, tumors, retinopathy of 
prematurity and persistent hyperplastic primary vitreous, corticosteroid-related 
glaucoma. 
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Flowchart 1. Congenital glaucoma management and follow-up 
1.6 Management  
Congenital glaucoma is essentially a surgical disease, in which surgery must be performed 
as early as possible. Goniotomy and trabeculotomy are usually the first procedures of choice 
(Flowchart 1).1 Both are safe and have a low incidence of complications. Factors that can 
decrease the success rate of initial trabeculotomy are the association of CG with others 
ocular anomalies (Peters, Sturge-Weber, Aniridia, etc.) and a corneal diameter of > 14 mm.2 
Usually, trabeculectomy is the option when previous goniotomies or trabeculotomies failed. 
Glaucoma drainage implants, non-penetrating surgery and cyclodestructive procedures are 
options also. 
Surgery is preferred for several reasons, including problems with compliance to medications, 
lack of knowledge about the systemic effects of medications in the infant and poor response 
www.intechopen.com
 Glaucoma - Basic and Clinical Concepts 
 
488 
to clinical treatment in infants. Moreover, surgery has a high success rate and low incidence 
of complications. 
Neither goniotomy nor trabeculotomy should be performed by surgeons inexperienced with 
the procedure. The first operation, whether goniotomy or trabeculotomy, has the greatest 
chance of success. 
a) Goniotomy 
Goniotomy is a very safe procedure when performed skillfully. Goniotomy is commonly the 
procedure of choice when corneal transparency permits adequate visualization of the angle 
(Figures 4 and 5). Corneal clouding only rarely prevents performance of goniotomy, 
particularly if cloudy epithelium is removed.4  
 
 
Fig. 4. Goniotomy (Courtesy Prof. Augusto Paranhos Jr.) 
 
 
Fig. 5. Goniotomy: see the iris configuration after incision (arrow) (Courtesy Prof. Augusto 
Paranhos Jr.) 
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It is necessary a goniolenses, like the Worst lens, to performed the goniotomy through direct 
visualization of the angle.  
Shaffer5 reported in a study on a series of 287 eyes, one or two goniotomies cured 94% of 
patients diagnosed between 1 month and 24 months of age. Goniotomy is unlikely to be 
effective if corneal diameter exceeds 14 mm, since in such eyes the Schlemm´s canal is 
obliterated.2 
b) Trabeculotomy 
Trabeculotomy may be necessary if corneal clouding prevents visualization of the angle 
(Figures 6 and 7). It was described initially by Burian in 1964, and posteriorly improved by 
Harms and Machensen.4 
 
 
Fig. 6. Trabeculotomy: see the enlargement of the corneoscleral junction (arrows) (Courtesy 
Prof. Augusto Paranhos Jr.) 
 
 
Fig. 7. Trabeculotomy: see the trabeculotome position (Courtesy Prof. Augusto Paranhos Jr.) 
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Trabeculotomy also has a high success rate, with most studies citing an 80% to 90% success 
rate.6 The incidence of complications is low, and includes hyphema, tears in Descemet´s 
membrane, ciclodialysis, iridodialysis and synechiae.3 
c) Update in trabeculectomy in congenital glaucoma 
Usually, trabeculectomy is the option when previous goniotomies or trabeculotomies failed.  
It has been reported that trabeculectomy without adjunctive antimetabolites in pediatric 
patients (less than 18 years of age) has a successful outcome in 30 % to 50% of cases.7-9 The 
50% rate is from a study with relatively short follow-up (mean 15.5 months).7 Studies with 
longer follow-up report a success rate of 30% to 35%. 8-9  
Mitomycin C (MMC) is a more potent inhibitor of fibroblast proliferation comparing to 5-
fluorouracil, and can be used intraoperatively, making it an attractive alternative for 
children in which previous surgery have failed. Clinical studies comparing the two 
antifibrotic agents have demonstrated a greater success rate and a greater degree of IOP 
with MMC.10-13 
Susanna et al. 14 had an overall success rate of 67% with a mean follow-up of 17 months in a 
series of 56 patients (79 eyes) with primary congenital glaucoma or developmental 
glaucomas underwent to trabeculectomy and adjunctive MMC. This success rate is better 
than it described for Giampani Jr et al.15 (55.26 %), probably because their longer follow-up 
(61.16 months).  
Beck et al.16 described a success rate of 58% after 24 months follow-up, although they had a 
large number of aphakic patients and a mean age of 91.2 months (7.6 years old). Sidoti et al. 
17 showed a success rate of 59% in a case series with 29 eyes, with a mean follow-up time of 
25.1 +/- 16 months. Giampani Jr et al.15 described a success rate of 90.2 % at 24-month, 78.7% 
at 36-month, 60.7 % at 48-month and 50.8 % at 60-month. 
 A very high success rate (95%) was described by Mandal et al. in a series of 19 mitomycin C 
trabeculectomies (Table 1).18 However, this study had only one patient under 1 year of age, 
which may be an important factor in that study’s superb success rate. Miller and Rice also 
showed a better prognosis for surgeries performed in older children.19 
Susanna et al. noted no changes in success rate when comparing eyes that had previous 
glaucoma surgery with those eyes that had no prior surgery.14 They suggested that the 
results of the group that had no prior glaucoma surgery were skewed by the presence of 
more eyes with poor prognoses, namely Axenfeld-Rieger syndrome, Sturge-Weber 
syndrome, and Aniridia. Beck et al.16 demonstrated a lower success rate for the group that 
had prior glaucoma surgery (55% compared with 70%), but without statistically significant 
difference. Giampani Jr et al. observed that the success rate was also higher in the group 
with no previous glaucoma surgery (64.28% compared with 51.21 %), but without 
statistically significant difference also (p= 0.32).15 
Endophthalmitis is a major complication associated with trabeculectomy, and it has been 
reported in children who have had trabeculectomy with mitomycin C.20 Giampani Jr et al. 
observed eight eyes with endophthalmitis in a total of 164 operated eyes (4.88 %).15 Beck and 
associates16 reported a higher endophthalmitis rate (8%), while Susanna et al14 reported one 
case in 79 eyes, and Wallace and associates21 noted one case in a series of 16 eyes. Mandal et 
al. had no cases of endophthalmitis in 19 eyes.18 Sidoti et al. described the highest infection 
complication rate of any reported series (10% of blebitis and 7% of endophthalmitis).17 
Probably, the higher MMC concentration utilized for them (0.5 mg/mL) explained, in part, 
that rate. In adults, the endophthalmitis rate after use of antimetabolites range from 2% to 
9%.22-24 
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Others complications, like overfiltration and hypotony maculopathy, are rarely observed 
after trabeculectomy with adjunctive mitomycin C in primary congenital glaucomas.15 
 
Authors Success rate (%) Follow-up (months) 
Giampani Jr. et al.15 55.26% 61.16 
Beck et al 16 58% 24 
Sidoti et al.17 59% 25.1 
Susanna et al.14 67% 17 
Mandal et al.18 95% 19.52 
Table 1. Trabeculectomy success rate in congenital glaucoma 
a) Aqueous drainage device surgery in congenital glaucoma 
Aqueous drainage devices were recommended in congenital glaucoma treatment when 
others procedures, like goniotomy, trabeculotomy and trabeculectomy failed (Figures 8 and 
9). Unfortunately, the long-term successful rate is generally poor.4 
O´Malley et al. described, in a chart review including 38 eyes with congenital glaucoma, a 
success rate about only 42% after 10 years follow-up.25 Khan et al. observed, in a small 
sample of 11 eyes with congenital glaucoma, a success rate of 90.9% after 2 years follow-up, 
using the silicone Ahmed valve.26 A long –term study using this device is needed to 
determine whether or not silicone as a good option in congenital glaucoma patients. 
The most common complications in congenital glaucoma patients are tube malpositioning 
with corneal touch, tube exposure, endophthalmitis, retinal detachment and ocular motility 
abnormalities.27 
b) Cyclodestructive procedures 
Cyclocryotherapy may be used when repeated surgery to improve outflow has failed. 
Transscleral cyclophotocoagulation has been used to produce thermal damage to the ciliary 
body and processes to decrease aqueous production. This method can have the advantage of 
less pain and inflammation than with cyclocryotherapy, but it still usually is reserved for 
cases in which surgery to improve aqueous outflow has failed.3 
 
 
Fig. 8. Ahmed valve in primary congenital glaucoma (Courtesy Augusto Paranhos Jr.) 
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Fig. 9. Ahmed valve: see the tube in the anterior chamber (arrow) (Courtesy Augusto 
Paranhos Jr.) 
c) Novel surgical procedures 
Viscocanalostomy was recently described as a novel surgical procedure to improve the 
aqueous outflow in congenital glaucoma patients. Kay et al. reviewed 39 eyes that 
underwent dilation and probing of Schlemm´s canal and viscocanalostomy. Surgical success 
was achieved in 27 of 39 eyes (69%) with an average follow-up of 22 months. In patients 
without history of previous surgery and the diagnosis of primary congenital or juvenile 
glaucoma, surgical success was achieved in 17 of 19 eyes (89%) with an average follow-up of 
20 months. There were no serious surgical complications associated with this procedure in 
this study.28 
Nouredin et al. studied the effectiveness of viscocanalostomy in patients with primary 
congenital glaucoma and compared it with trabeculotomy ab externo. Eight patients with 
bilateral primary congenital glaucoma were enrolled in the study. After establishing the 
diagnosis, the more severely affected eye was randomly selected to undergo either 
trabeculotomy ab externo or viscocanalostomy, whereas the second eye underwent the other 
surgery 2 weeks after the first. The mean standard deviation (SD) follow-up period was 12.5 
(1.86) months. A drop in IOP was noted in both groups at week 1, month 6 and at the last 
follow-up visit (p<0.001).29 Viscocanalostomy proved to be as effective as trabeculotomy ab 
externo in lowering IOP in this small sample study. Nevertheless, long-term follow-up 
studies using viscocanalostomy are required to determine it as a good option in congenital 
glaucoma patients. 
2. Glaucomas associated with congenital anomalies 
2.1 Iridocorneal dysgenesis 
Iridocorneal dysgenesis consists of overlapping rare congenital disorders involving the 
cornea and the iris, some of which may be associated with glaucoma. These conditions occur 
as a result of abnormal neural crest cell development and are: Axenfeld-Rieger syndrome, 
Peters anomaly and aniridia.30 
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a) Axenfeld-Rieger syndrome 
This syndrome is characterized by a mesodermal dysgenesis with different degrees of 
presentation. The Axenfeld anomaly shows a prominent and anteriorly displaced Schwalbe´s 
line (called posterior embryotoxon) onto which are attached strands of peripheral iris tissue 
(Figure 10). The secondary glaucoma is rare in this condition. On the other hand, the Rieger 
anomaly is an autosomal dominant condition with a high degree of penetrance, where 
mutations in PITX2 and FOXC1 genes were described.31 Involvement is usually bilateral but 
not always symmetrical. The slit-lamp biomicroscopy may show posterior embryotoxon, iris 
stromal hypoplasia, corectopia, pseudopolycoria and ectropion uveae (Figure 11). The 
gonioscopy in mild cases shows Axenfeld anomaly. In severe cases, broad leaves of the iris 
stroma adhere to the corneal anterior to Schwalbe´s line. Glaucoma develops in about 50% 
of cases, usually during the early childhood.4 
 
 
Fig. 10. Posterior embryotoxon onto which are attached strands of peripheral iris (Courtesy 
Prof. Ernst Oltrogge) 
 
 
Fig. 11. Rieger´s anomaly showing corectopia and pseudopolycoria (Courtesy Prof. Celso 
Antonio de Carvalho) 
www.intechopen.com
 Glaucoma - Basic and Clinical Concepts 
 
494 
The Rieger´s syndrome consists of Rieger´s anomaly in association with systemic 
malformations, like hypodontia (a decrease in the number of teeth), microdontia (a decrease 
in the teeth size) and facial malformations, including hypoplasia of the maxilla, a broad flat 
nasal bridge, telecanthus (a lateral displacement of the medial canthus) and hypertelorism 
(an increased distance between the bony orbits).30 Others anomalies include redundant 
paraumbilical skin. 
Some authors proposed the term Axenfeld-Rieger syndrome for all clinical variations within 
this spectrum of developmental disorders.4 
The glaucoma treatment is surgical in the most cases of these disorders. Options of 
incisional surgery include goniotomy, trabeculotomy and trabeculectomy. The first two 
procedures have been used in infants with limited success. Trabeculectomy with adjunctive 
mitomycin C is the surgical procedure of choice for most patients with glaucoma associated 
with Axenfeld-Rieger syndrome. The long-term successful rates, however, are poor.14,15 
b) Peters anomaly 
This anomaly is characterized by a congenital central cornea leukoma associated with a 
defect in the corresponding posterior stroma and Descemet´s membrane, with synechiae 
extending from the central iris to the periphery of the corneal opacity (Figure 12).32 Some 
patients may have a central keratolenticular adherence with shallowing of the anterior 
chamber, whereas others may have an anterior polar cataract. A variety of less commonly 
associated ocular findings include microcornea, microphthalmia, cornea plana, aniridia, 
sclerocornea and corectopia. An association between Peters anomaly and the systemic 
alterations seen in Axenfeld-Rieger syndrome is not uncommon.4 
 
 
Fig. 12. Peters anomaly after trabeculectomy with MMC (see the bleb – arrow) (Courtesy 
Prof. Ernst Oltrogge) 
Most cases are sporadic, although autosomal recessive inheritance and chromosomal defects 
have been described. About 80% percent of cases are bilateral. The pathogenesis involve a 
defect neural crest cell migration in the sixth to eight weeks of fetal development, during 
which time the anterior segment of the eye is formed.30 
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Glaucoma occurs in 50% to 70% of cases. Elevated intraocular pressure unresponsive to 
topical medications should be treated surgically, before penetrating keratoplasty is 
performed. Trabeculectomy with use of antimetabolites is the procedure of choice in these 
cases.32 Unfortunately, the long-term visual outcome and glaucoma control are usually 
poor.4 
c) Aniridia 
It is a bilateral condition with life-threatening associations. It occurs as a result of abnormal 
neuroectodermal development secondary to a mutation in the PAX6 gene linked to 11p13.30 
This gene controls the development of a number of structures, hence the broad nature of 
ocular and systemic manifestations. The inheritance is autosomal dominant in most cases.  
The aniridia is variable in severity, ranging from minimal to total (Figure 13). However, even 
eyes with total involvement usually show a residual iris tissue in the angle on gonioscopy. 
Others ocular findings include corneal lesions (leukomas, microcornea and sclerocornea), 
cataract, aphakia and lens subluxation, foveal hypoplasia, choroidal coloboma and optic 
nerve hypoplasia. The systemic manifestations include Wilm´s tumor, genitourinary 
anomalies, mental retardation and cerebellar ataxia. 
Glaucoma occurs in approximately 2/3 of cases and usually presents in late childhood and 
adolescence.4 The intraocular pressure control is usually difficult, and the medical therapy is 
inadequate in most cases. The surgical procedures, like goniotomy and trabeculotomy, show 
poor long-term results. The trabeculectomy with adjunctive antimetabolites is the procedure 
of choice is most cases. However, the long-term results are also disappointing.14-16  
 
 
Fig. 13. Total aniridia (Courtesy Prof. Ernst Oltrogge) 
2.2 Phacomatoses 
The Phacomatoses are characterized by the formation of hamartias and hamartomas in the 
eye, central nervous system, skin and viscera. They are hereditary disorders with variable 
penetrance and expressivity. 
a) Sturge-Weber syndrome 
Also called encephalotrigeminal angiomatosis is characterized by facial haemangioma 
(naevus flammeus –Figure 14), choroidal haemangioma and intracranial meningeal 
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angiomata. The haemangioma usually involves the first and second divisions of the 
trigeminal nerve. The disease has little familial tendency, and no sexual or racial 
predisposition. Chromosomal abnormalities have been reported in some patients, and the 
disorder may be a dominant trait with incomplete penetrance.33 
Glaucoma develops in about 30% of patients, ipsilateral to the facial haemangioma, 
especially if the lesion affects the upper eyelid. 
The glaucoma pathogenesis involves a trabeculodysgenesis and an elevated episcleral 
venous pressure. The medical treatment with prostaglandin analogues (enhancing uveo-
scleral outflow) may be useful in some cases. Nevertheless, surgical approach is necessary  
in most cases. The goniotomy may be successful in eyes with angle anomalies 
(trabeculodysgenesis). The combined trabeculotomy-trabeculectomy gives good results in 
early-onset cases, before the buphthalmos appearing. Surgery always carries a high risk of 
choroidal effusion and suprachoroidal haemorrhage. Adverse consequences of this may be 
minimized by performing a posterior sclerotomy before opening the eye.34  
 
 
Fig. 14. Naevus flammeus in Sturge-Weber syndrome 
b) Neurofibromatosis 
It is a neuroectodermal dysplasia characterized by tumor-like formations (neurofibromas) 
derived from the proliferation of peripheral nerve elements. The neurofibromas can occur in 
the central nervous system, central and peripheral nerves, as well in skin and mucus 
membranes. Inheritance is autosomal dominant with irregular penetrance and variable 
expressivity. Glaucoma is uncommon, usually unilateral and congenital. Classically, 
neurofibromatous involvement of the upper lid is present. Glaucoma is present in 50% of all 
eyes with plexiform neuroma.4 
Many mechanisms have been postulated as causes of glaucoma in neurofibromatosis. The 
elevated intraocular pressure may occur secondary to obstruction of aqueous outflow by 
neurofibromatous tissue, developmental angle anomaly or angle closure caused by 
neurofibromatous thickening of the ciliary body or synechiae. 
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Many surgical procedures, like goniotomy, trabeculotomy, trabeculectomy and 
cyclodestructive procedures have been reported for the glaucoma treatment. 35 However, 
the overall rate of success of surgery in literature is much lower than that for primary 
congenital glaucoma.33 
3. Secondary infantile glaucoma 
The secondary infantile glaucomas may be associated with non-hereditary congenital 
diseases, trauma or intraocular tumors. The secondary glaucoma after congenital cataract 
surgery is usually a disease with poor visual outcome. Fortunately, the modern cataract 
surgery and the novels topical anti-inflammatory drugs reduced the complications after 
congenital cataract surgery, like vitreous loss, retinal detachment and glaucoma. 
Nevertheless, the treatment of elevated intraocular pressure after congenital cataract surgery 
is usually difficult and a trabeculectomy with adjunctive antimetabolite may be necessary. 4  
Others secondary infantile glaucoma causes include persistent hyperplastic primary 
vitreous, retrolental fibroplasia, corticosteroid-related glaucoma and retinoblastoma. 
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